TrialHaematologica2011

Relationship between pharmacokinetic profile of subcutaneously administered alemtuzumab and clinical response in patients with chronic lymphocytic leukemia.

Michela Montagna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.